SoftBank Vision Fund L.P., 10% Owner at Urovant Sciences Ltd. (UROV), bought 31,451 shares at $8.53 ($262K) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market purchase of $262k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.53 | 6,541 | $56K | 21.3% |
| 2 | $8.53 | 6,541 | $56K | 21.3% |
| 3 | $8.21 | 6,706 | $55K | 21.0% |
| 4 | $8.21 | 6,706 | $55K | 21.0% |
| 5 | $8.17 | 4,957 | $40K | 15.4% |
| Total | $8.34 avg | 31,451 |
| $262K |
| 100% |
| Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $248K | — | Filing → |
| AXON | BUY | 2019-03-19 | $20.0M | — | Filing → |